Prostate Cancer and Use of PSA


February 18th, 2009 - February 18th, 2012
1.00 AMA PRA Category 1 Credit Hours

Description

According to the National Institutes of Health, levels of a substance called prostate specific antigen (PSA) is often high in men with prostate cancer. However, PSA can also be high with other prostate conditions. Since the PSA test became common, most prostate cancers are found before they cause symptoms. This activity is supported in part by educational grants from Merck and Astellas.
The webcast is no longer available.
Post-Test taking for this webcast is no longer available.

Dates and Times

End Date: 2/18/2012

Objectives

Upon completion of this educational activity, the participant will be able to: 1.) Review of the prostate specific antigen utilization for the diagnoses and treatment of prostate cancer. 2.) Explain screening for prostate cancer.

Webcasts Files

File Link

PDF of Slides

Download

Accreditation

The Center for Continuing Medical Education (CCME) at The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians

The Center for Continuing Medical Education (CCME) at The Ohio State University designates this webcasts for a maximum of 1.00 AMA PRA Category 1 Credit(s) . Physicians should only claim credit commensurate with the extent of their participation in the activity.